Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1234.60
-10.90 (-0.88%) Dr Reddy's Laboratories earmarks capex of around Rs 1,000 crore for current fiscal
Date: 24-05-2021Dr Reddy's Laboratories has earmarked a capex of around Rs 1,000 crore for the current fiscal as it remains positive about sustaining its growth trends in the current fiscal and beyond. The Hyderabad based firm invested about Rs 1,000 crore in the 2020-21 fiscal.
Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.